1. Gastric adenocarcinoma in young adult patients: patterns of care and survival in the United States

   • Brian De
   • Ryan Rhome
   • Celina Ang

   Original Article 24 April 2018 Pages: 889 - 899

   

2. Tree nut, peanut, and peanut butter consumption and the risk of gastric and esophageal cancer subtypes: the Netherlands Cohort Study

   • Lisette Nieuwenhuis
   • Piet A. van den Brandt

   Original Article Open access 28 March 2018 Pages: 900 - 912

   

3. Body mass index and mortality in patients with gastric cancer: a large cohort study

   • Jung Hwan Lee
   • Boram Park
   • Soo-Jeong Cho

   Original Article 12 April 2018 Pages: 913 - 924

   

4. Poor prognosis in Epstein–Barr virus-negative gastric cancer with lymphoid stroma is associated with immune phenotype

   • Charles J. Cho
   • Hyo Jeong Kang
   • Seung-Jae Myung

   Original Article 07 April 2018 Pages: 925 - 935

   

5. Association between ALDH2 and ADH1B polymorphisms, alcohol drinking and gastric cancer: a replication and mediation analysis

   • Kuka Ishioka
   • Hiroyuki Masaoka
   • Keitaro Matsuo

   Original Article 03 April 2018 Pages: 936 - 945

6. Cancer–adipose tissue interaction and fluid flow synergistically modulate cell kinetics, HER2 expression, and trastuzumab efficacy in gastric cancer

   • Takashi Akutagawa
   • Shigehisa Aoki
   • Shuji Toda

   Original Article 25 April 2018 Pages: 946 - 955

   

7. Gastrokine 1 protein is a potential theragnostic target for gastric cancer

   • Jung Hwan Yoon
   • In-Hye Ham
   • Won Sang Park

   Original Article Open access 27 April 2018 Pages: 956 - 967

   

8. SOCS1 gene therapy has antitumor effects in imatinib-resistant gastrointestinal stromal tumor cells through FAK/PI3 K signaling

   • Takahito Sugase
   • Tsuyoshi Takahashi
   • Tetsuji Naka

   Original Article 05 April 2018 Pages: 968 - 976

   

9. ypTNM staging after neoadjuvant chemotherapy in the Chinese gastric cancer population: an evaluation on the prognostic value of the AJCC eighth edition cancer staging system

   • Ziyu Li
   • Yinkui Wang
   • Jiafu Ji

   Original Article Open access 10 May 2018 Pages: 977 - 987

   

10. Diagnostic accuracy of demarcation using magnifying endoscopy with narrow-band imaging for Helicobacter pylori-uninfected undifferentiated-type early gastric cancer

    • Yusuke Horiuchi
    • Junko Fujisaki
    • Tomohiro Tsuchida

    Original Article 13 March 2018 Pages: 988 - 997

    

11. Gastric washing by distilled water can reduce free gastric cancer cells exfoliated into the stomach lumen

    • Atsuko Ohki
    • Nobutsugu Abe
    • Masanori Sugiyama

    Original Article 25 April 2018 Pages: 998 - 1003

    

12. Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006–2014 using propensity score matching

    • Naruhiko Ikoma
    • Prajnan Das
    • Brian D. Badgwell

    Original Article 05 May 2018 Pages: 1004 - 1013

    

13. A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trial

    • Naoto Takahashi
    • Mitsuro Kanda
    • Yasuhiro Kodera

    Original Article 13 March 2018 Pages: 1014 - 1023

    

14. Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center

    • Yosuke Kano
    • Manabu Ohashi
    • Takeshi Sano

    Original Article 26 April 2018 Pages: 1024 - 1030

    

15. Comparative effectiveness of adjuvant treatments for resected gastric cancer: a network meta-analysis

    • Zhaolun Cai
    • Yiqiong Yin
    • Bo Zhang

    Original Article 04 May 2018 Pages: 1031 - 1040

    

16. Ramucirumab for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first-line platinum- or fluoropyrimidine-containing combination therapy in Japanese patients: a phase 2, open-label study

    • Kensei Yamaguchi
    • Kazumasa Fujitani
    • Taroh Satoh

    Original Article 05 March 2018 Pages: 1041 - 1049

    

17. Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan

    • Chihiro Kondoh
    • Shigenori Kadowaki
    • Kei Muro

    Original Article 16 April 2018 Pages: 1050 - 1057

    

18. First report of an Asian family with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) revealed with the germline mutation of the APC exon 1B promoter region

    • Yasuhiro Mitsui
    • Reiko Yokoyama
    • Tetsuji Takayama

    Case Report 02 July 2018 Pages: 1058 - 1063

    

19. Transcriptional analysis of immune genes in Epstein–Barr virus-associated gastric cancer and association with clinical outcomes

    • Raghav Sundar
    • Aditi Qamra
    • Patrick Tan

    Short Communication 18 June 2018 Pages: 1064 - 1070

    

20. After propensity score matching in long-term oncologic outcomes of robotic gastrectomy for gastric cancer compared with laparoscopic gastrectomy

    • Jong Won Kim

    Letter to the Editor 16 June 2018 Pages: 1071 - 1071

21. Correction to: Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center

    • Yosuke Kano
    • Manabu Ohashi
    • Takeshi Sano

    Correction 13 June 2018 Pages: 1072 - 1072